Impact Of BCR-ABL1 Monitoring Among Patients With BCR-ABL1-Positive B-Acute Lymphoblastic Leukemia
Acute lymphoblastic leukaemia (ALL) with BCR-ABL1 confers a high risk of relapse and a poor prognosis. Access to the tyrosine kinase inhibitor as part of the treatment strategy has changed the risk stratification for ALL patients harbouring this fusion gene. As BCR-ABL1 is routinely quantified for t...
Saved in:
Internet
https://oarep.usim.edu.my/bitstreams/83dbe9d5-4405-4d32-b0ff-6e11976b1561/downloadhttps://oarep.usim.edu.my/bitstreams/652261f0-5b8e-400f-a96e-f21afb0ab30b/download
https://oarep.usim.edu.my/bitstreams/946645cb-38f0-46bb-976f-6183f92f2139/download
https://oarep.usim.edu.my/bitstreams/fbae4e9f-bd7b-40d3-950b-d6014caa032b/download
https://oarep.usim.edu.my/bitstreams/bf7c4432-eff4-4f6c-a807-8cbe8d384be9/download
https://oarep.usim.edu.my/bitstreams/0de4d4a7-34b2-4c70-8f23-c00d3f81b18e/download
https://oarep.usim.edu.my/bitstreams/da36ff99-b439-47a9-a7e5-a5f979e69a7e/download
https://oarep.usim.edu.my/bitstreams/23773bf2-a773-431a-866e-2e8e94bc6eec/download